Pharmaxis Ltd logo

Pharmaxis Ltd

ASX:PXS.AX

Overview | Financials
Company Name Pharmaxis Ltd
Symbol PXS.AX
Currency AUD
Price 0.028
Market Cap 20,233,192
Dividend Yield 0%
52-week-range 0.027 - 0.065
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Gary Jonathan Phillips BPharm, MBA
Website https://www.pharmaxis.com.au

An error occurred while fetching data.

About Pharmaxis Ltd

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an

Related Stocks

Dimerix Limited logo

Dimerix Limited

DXB.AX

0.38 AUD

Patrys Limited logo

Patrys Limited

PAB.AX

0.007 AUD

Imagion Biosystems Limited logo

Imagion Biosystems Limited

IBX.AX

0.023 AUD

PainChek Limited logo

PainChek Limited

PCK.AX

0.032 AUD

Vectus Biosystems Limited logo

Vectus Biosystems Limited

VBS.AX

0.08 AUD

Cynata Therapeutics Limited logo

Cynata Therapeutics Limited

CYP.AX

0.19 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD